While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston ...

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and ...

Boston Scientific’s AI leadership, global growth, and strong R&D make it a long-term winner despite valuation and regulatory ...

Boston Scientific has updated the instructions for use for products deployed in the implantation of its Watchman heart device ...

The FDA is reviewing Boston Scientific's defibrillator leads after reports of rising shock impedance and 16 related deaths.

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

Boston Scientific (BSX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep ...

The FDA has issued an early communication to warn of updated instructions for use for certain Boston Scientific Watchman access systems.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

The FDA has issued an alert about a potentially high-risk issue involving models of Boston Scientific’s Watchman Access Systems, which are used to provide vascular and transseptal access during ...

Boston Scientific warned of the potential for rising low-voltage shock impedance (LVSI) associated with Reliance ...